WO2009027823A3 - Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. - Google Patents

Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. Download PDF

Info

Publication number
WO2009027823A3
WO2009027823A3 PCT/IB2008/002346 IB2008002346W WO2009027823A3 WO 2009027823 A3 WO2009027823 A3 WO 2009027823A3 IB 2008002346 W IB2008002346 W IB 2008002346W WO 2009027823 A3 WO2009027823 A3 WO 2009027823A3
Authority
WO
WIPO (PCT)
Prior art keywords
processes
tissular
trophism
dermal
wound healing
Prior art date
Application number
PCT/IB2008/002346
Other languages
French (fr)
Other versions
WO2009027823A9 (en
WO2009027823A2 (en
Inventor
Ana Maria Cruces
Walter Montagni
Andrea Vanesa Giuliani
Patricia Viviana Duarte
Rosalia Mlynarz
Original Assignee
Ramirez D Onofrio Alvaro D
Ana Maria Cruces
Walter Montagni
Andrea Vanesa Giuliani
Patricia Viviana Duarte
Rosalia Mlynarz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramirez D Onofrio Alvaro D, Ana Maria Cruces, Walter Montagni, Andrea Vanesa Giuliani, Patricia Viviana Duarte, Rosalia Mlynarz filed Critical Ramirez D Onofrio Alvaro D
Publication of WO2009027823A2 publication Critical patent/WO2009027823A2/en
Publication of WO2009027823A3 publication Critical patent/WO2009027823A3/en
Publication of WO2009027823A9 publication Critical patent/WO2009027823A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses pharmaceutical compositions for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes for internal and external use, containing gentamicin sulphate, metronidazole, papain, metronidazole Balsam of Peru, and an excipient or vehicle pharmaceutically acceptable.
PCT/IB2008/002346 2007-08-29 2008-08-29 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application. WO2009027823A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP20070103846 2007-08-29
ARP070103846A AR062835A1 (en) 2007-08-29 2007-08-29 A SELECTIVE STIMULATING COMPOSITION OF CICATRIZATION ITS PREPARATION AND APPLICATION

Publications (3)

Publication Number Publication Date
WO2009027823A2 WO2009027823A2 (en) 2009-03-05
WO2009027823A3 true WO2009027823A3 (en) 2009-04-23
WO2009027823A9 WO2009027823A9 (en) 2009-09-03

Family

ID=40225122

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/002346 WO2009027823A2 (en) 2007-08-29 2008-08-29 Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application.

Country Status (2)

Country Link
AR (1) AR062835A1 (en)
WO (1) WO2009027823A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012095702A1 (en) * 2011-01-13 2012-07-19 Medestea Internazionale S.P.A. A composition for the regeneration of atrophic tissues
CN102241712B (en) * 2011-05-23 2014-04-02 南阳普康药业有限公司 Decolorizing method for gentamicin sulfate production
CN104435345A (en) * 2014-11-11 2015-03-25 四川金堂海纳生物医药技术研究所 Orally taken medicine for treating pulpitis and preparation method thereof
BE1024364B9 (en) * 2016-06-29 2018-03-07 Holding Tolpoort Bvba COMPOSITION FOR TREATMENT OF PERNIOSIS
CN116407611A (en) * 2021-12-29 2023-07-11 四川好医生攀西药业有限责任公司 Application of polypeptide in preparation of products for preventing or treating skin injury diseases

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2028130A (en) * 1978-05-30 1980-03-05 Acf Chemiefarma Nv Pharmaceutical wound-treating compositions containing allantoin
WO2000038617A2 (en) * 1998-12-24 2000-07-06 Four Star Partners Compositions and methods of using the same
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
WO2007084127A1 (en) * 2006-01-20 2007-07-26 Verdon Peters Use of gluten for wound treatment as active healing ingredient
WO2007099398A2 (en) * 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2028130A (en) * 1978-05-30 1980-03-05 Acf Chemiefarma Nv Pharmaceutical wound-treating compositions containing allantoin
WO2000038617A2 (en) * 1998-12-24 2000-07-06 Four Star Partners Compositions and methods of using the same
US20040151765A1 (en) * 2001-09-18 2004-08-05 Ritchie Branson W. Methods and compositions for wound management
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
WO2007099398A2 (en) * 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin
US20070154402A1 (en) * 2005-10-24 2007-07-05 Collegium Pharmaceutical, Inc. Topical Pharmaceutical Foam Composition
WO2007084127A1 (en) * 2006-01-20 2007-07-26 Verdon Peters Use of gluten for wound treatment as active healing ingredient

Also Published As

Publication number Publication date
WO2009027823A9 (en) 2009-09-03
AR062835A1 (en) 2008-12-10
WO2009027823A2 (en) 2009-03-05

Similar Documents

Publication Publication Date Title
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
IL195142A (en) Substituted arylimidazolone and triazolone, process for their preparation and pharmaceutical compositions comprising the same for the treatment or prophylaxis of diseases
WO2006119329A3 (en) Compositions and methods for the treatment of neurodegenerative diseases
WO2008089268A3 (en) Methods and compositions for treating conditions associated with infection and/or inflammation
WO2009121039A3 (en) Administration of benzodiazepine compositions
WO2010003313A8 (en) Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof
WO2008035373A3 (en) Highly pure polysialic acid and process for preperation thereof
WO2007117971A3 (en) Ocular allergy treatments
WO2007051468A3 (en) Preparation of an antibiotic crystalline fusidic acid
WO2010009200A3 (en) Methods for treating oral cavity infections with chlorine dioxide
WO2008008495A3 (en) Stereocomplex-forming composition and implantable medical device comprising same
WO2010056656A3 (en) Preparation of crystalline palonosetron hydrochloride
WO2009027823A3 (en) Pharmaceutical composition for selective stimulation of wound healing processes, dermal-epidermal normal tissular trophism processes, its preparation and application.
WO2007123740A3 (en) Pharmaceutical compositions for promoting wound healing
WO2007109799A3 (en) Polymorphs of eszopiclone malate
WO2011077239A3 (en) Slow release pharmaceutical compositions of iloperidone
WO2008051564A3 (en) Crystalline forms of palonosetron hydrochloride
WO2008062436A3 (en) Antimicrobial derivatives of anacardic acid and process for preparing the same
HK1103961A1 (en) Medicament for the treatment of fungal infections, particularly aspergillosis
WO2009142428A3 (en) Pharmaceutical composition for the treatment of premature ejaculation
WO2009120389A8 (en) Oral and injectable formulations of tetracycline compounds
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
EP1584335A3 (en) Active substance combination comprising a carbinol composition and an opioid
WO2008081268A3 (en) Pharmaceutical compositions of entacapone
EP1637167A3 (en) New injectable formulations containing progesterone

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08807036

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC

122 Ep: pct application non-entry in european phase

Ref document number: 08807036

Country of ref document: EP

Kind code of ref document: A2